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South Africa has the highest prevalence of human immunodeficiency 
virus (HIV) infection in the world, with KwaZulu-Natal Province 
at the epicentre of the epidemic.1-3 In 2009, 280 000 South African 
children <15 years old were infected with HIV.4-7 The primary cause 
of death is pulmonary disease, which is also the most common 
clinical feature of HIV.8
Chest radiographs are widely available and relatively inexpensive. 
In the assessment and management of acute and chronic disease in 
HIV-infected children, they provide an initial differential diagnosis,9 
suggest the diagnosis of pulmonary tuberculosis (TB), detect extra-
pulmonary disease,10 provide a radiological baseline before initiation 
of antiretroviral therapy (ART), and monitor treatment response,11 
including the development of immune reconstitution inflammatory 
syndrome (IRIS).
In adult patients, specific HIV-related infections and neoplasms 
occur within defined CD4 lymphocyte count ranges.12 There are no 
similar reports concerning HIV-infected children. Identification of 
pulmonary disease radiographic patterns within paediatric clinical 
and immunological HIV groups will assist the recognition of new 
disease, chronic disease, and diseases following the initiation of ART.
We aimed to determine the prevalence of specific radiographic 
features in HIV-infected children preparing to initiate ART so as to 
develop a guideline of expected baseline radiographic appearances; 
and the radiological features which predominate at specific levels 
of immune suppression, which could narrow the radiological 
differential diagnosis.
Materials and methods
A PubMed database search in March 2008 revealed no English-
language articles relating specifically to the prevalence of radiographic 
patterns in children with HIV infection and correlating these with 
CD4 levels of immunity or clinical presentation.
The study was approved by the Biomedical Research Ethics 
Committee, University of KwaZulu-Natal in August 2009 (Ref: 
BE031/09).
We performed a retrospective review of the clinical records and 
baseline chest radiographs of 100 consecutive children presenting as 
outpatients for their first screening visit for initiation of ART from 
January to July 2009. The data were collected during August 2009 
at a single site – the paediatric ART clinic at Edendale Hospital in 
Pietermaritzburg. The chest X-rays were reported by a paediatric 
radiologist, and the radiological findings compared with the baseline 
World Health Organization (WHO) clinical staging and immune 
status (CD4 lymphocyte results).
Patients included were those aged 6 months to 12 years who were 
referred to the paediatric ART clinic for initiation of ART. They were 
confirmed HIV-positive (on HIV antibody and/or virology testing) and 
deemed eligible for ART according to clinical and/or immunological 
criteria based on the 2006 WHO guidelines13 as follows:
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Background. South Africa’s HIV mortality is primarily due to 
pulmonary disease. No evidence exists regarding a correlation 
between specific chest radiographic patterns and CD4 levels of 
immunity in HIV-infected children.
Objectives. We aimed to determine the prevalence of specific 
radiographic features in HIV-infected children initiating anti-
retroviral therapy (ART) to develop a guideline of expected 
baseline radiographic appearances, and the radiographic features 
that predominate at specific levels of immune suppression (defined 
by CD4 percentage ranges), which would narrow the radiological 
differential diagnosis.
Method. Retrospective review of the baseline chest radiographs of 
92 consecutive paediatric outpatients initiating ART.
Results. Normal radiographs were reported in 54% of patients. 
Those with radiographic abnormalities had parenchymal disease 
(34%), mediastinal disease (22%) and pleural disease (1%). 
Parenchymal disease was predominantly air space (28%), and 
mediastinal disease was predominantly cardiomegaly (21%); 
lymphadenopathy was rare (1%). Radiological appearances of TB 
were seen in 9% of patients. A statistically significant association 
was shown between immune suppression and air space disease 
(p=0.049) with a relative risk of 0.46 (95% CI 0.24 - 0.88) for air 
space disease in immune-suppressed children. This association was 
independent of age.
Conclusion. Baseline chest radiographs in paediatric outpatients 
presenting for initiation of ART are predominantly normal, but 
also demonstrate a significant number of pathological radiological 
features – primarily air space disease and cardiomegaly. The only 
statistically significant association between radiographic features 
and immune suppression was air space disease, which correlated 
with a higher level of immunity.
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•    Recurrent hospitalisations (>2 admissions per year) for HIV 
complications or prolonged hospitalisation for HIV (>4 weeks)
OR
•    Symptomatic children
   •   <1 year of age: WHO stage II, III and IV, or CD4 ≤35%
   •   1 - 5 years of age: WHO stage III and IV, or CD4 ≤20%
   •   >5 years of age: WHO stage III and IV, or CD4 <15%.
Initial work-up and preparation at the ART clinic includes a 
baseline clinical assessment and staging, blood specimens for baseline 
CD4 levels, and a frontal chest X-ray to exclude TB.11
The WHO clinical staging system determines disease severity and 
eligibility for ART, particularly in resource-limited settings where 
CD4 testing is not available. Clinical stages are categorised as 1 - 4, 
progressing from primary HIV infection to advanced HIV/AIDS.
We classified patients according to their immune status, based 
on CD4 percentages according to the 1994 Revised HIV Paediatric 
Classification System14 as follows:
•   ≥25% (no immune suppression)
•   15 - 24 % (moderate immune suppression)
•   <15% (severe immune suppression).
Patients were excluded if the chest X-ray reference number was 
unrecorded, if the chest X-ray could not be located in the ART clinic 
or the filing room of the radiology department, or if the X-ray was of 
such poor technical quality that it could not be interpreted.
Chest radiographic findings were assessed by a paediatric radiologist 
according to a specified format that categorised findings into 3 main 
groups: mediastinal, pleural and parenchymal pathology. Mediastinal 
pathology included cardiomegaly and lymphadenopathy; pleural 
pathology included pleural fluid/thickening and pleural calcification; 
and parenchymal pathology included air space disease (focal and 
diffuse), cavities, nodules, bronchial disease, fibrocystic change and 
air trapping. The suspected presence or absence of pulmonary TB 
was also recorded.
The following were recorded: cardiomegaly if the cardiothoracic 
ratio was >60% in children <2 years of age, or >50% in children 
>2 years; lymphadenopathy if there were airway compression or 
deviation, or if there were lobulated masses extending beyond the 
cardiac or thymic shadow; pleural fluid/thickening if there were 
either linear lamellar densities along the lateral chest wall or blunted 
costophrenic angles; bronchial disease as either bronchiectasis 
(tramline or signet ring signs) or bronchial wall thickening with or 
without air trapping; air trapping as bilateral if >6 anterior ribs were 
visible at the mid-diaphragm, and as unilateral if the hemithoraces 
were asymmetrical in size and density in the absence of rotation; 
pulmonary TB in the presence of lymphadenopathy (with or without 
calcification), and/or nodular disease (miliary or larger), and/or 
cavitation (including bronchiectasis).
The reporting radiologist was blinded to the clinical and 
immunological data by performing the radiographic interpretation 
independently of clinical and immunological data collection.
Statistical analysis
Frequencies are described as a number and/or percentage. Descriptive 
statistics (frequencies and cross tabulations – Pearson’s chi-square 
test and relative risk analysis) were conducted using SPSS Statistics 
17.0 for Windows (SPSS, Chicago, IL). Mantel-Haenszel stratified 
relative risk was calculated in Epi Info version 3.4.3 (CDC).
Results
Of the 100 children, a total of 92 were included in the study 
(radiographs of 6 were missing and 2 were of inadequate technical 
quality for interpretation). Ages ranged from 6 months to 12.8 years 
(median age 4.6 years; mean age 5.4 years); 9 (10%) were <12 months, 
41 (45%) were 1 - 5 years, and 42 (46%) were 6 - 12 years; 49 (53%) 
were boys and 41 (45%) were girls (2 unrecorded).
Clinically, of the total, 11 (12%) were WHO classification stage 
I, 7 (8%) stage II, 51 (55%) stage III, and 23 (25%) stage IV HIV. 
Immunologically, 16 (19%) were not immune-suppressed (CD4 % 
≥25%), 31 (36%) had moderate immune suppression (CD4 %: 15 - 
24%) and 39 (45%) were severely immune-suppressed (CD4 % <15%) 
(CD4% of 6 children was unrecorded).
Fifty (54%) children had normal radiographs, of whom 7 (14%) 
were stage I, 1 (2%) stage II, 31 (62%) stage III and 11 (22%) stage 
IV HIV. Immunologically, 7 (14%) were not immune-suppressed, 21 
(42%) had moderate immune suppression, and 19 (38%) were severely 
immune-suppressed (CD4 % results of 3 children unrecorded).
Forty-two (46%) had abnormal radiographs, of whom 4 (10%) 
were stage I, 6 (14%) stage II, 20 (48%) stage III, and 12 (29%) stage 
IV HIV. Immunologically, 9 (21%) were not immune-suppressed, 
10 (24%) had moderate immune suppression, and 20 (48%) were 
severely immune-suppressed (CD4 % results of 3 unrecorded).
Chest radiographs revealed that 31 (34%) subjects had parenchymal 
disease, 20 (22%) mediastinal disease, and 1 (1%) had pleural disease. 
Parenchymal disease was predominantly air space disease – 26 (28%). 
Focal air space disease was present in 14 patients, diffuse air space 
disease in 12, and air trapping and bronchial disease in 9 (10%) and 
6 (7%) patients respectively. Mediastinal disease (predominantly 
cardiomegaly) was seen in 19 (21%). Lymphadenopathy was seen in 
only 1 patient (1%). Radiological appearances of TB were reported 
in 8 (9%) patients – all of whom were in the more severe clinical 
categories (WHO stages III and IV), and two-thirds had severe 
immune suppression immunologically.
Table I summarises relevant radiographic features according to the 
level of immune suppression.
Pearson’s chi-square analysis showed no statistically significant 
association between the presence or absence of radiological findings 
and clinical staging (p=0.104) or level of immune suppression 
(p=0.177).
The only radiographic finding with a statistically significant 
association with immune suppression was air space disease (p=0.049), 
which was even more significant (p=0.029) when the immune 
suppression categories were grouped into present (moderate or 
severe immune suppression) and absent (no immune suppression). 
The relative risk (RR) of air space disease in those with immune 
suppression v. those without immune suppression was 0.46 (95% 
CI 0.24 - 0.88), which implies that the presence of air space disease 
correlates with a higher level of immunity (or conversely that 
radiographic air space disease is less likely to be seen in patients with 
moderate or severe immune suppression).
Stratified analysis of immune suppression and air space disease by 
age group revealed similar trends within all 3 age groups. The Mantel-
Haenszel adjusted RR for the association between air space disease and 
immune suppression (adjusted for age group) was 0.42 (95% CI 0.23 - 
0.76), confirming that this finding was independent of age.
Pearson’s chi-square analysis also showed statistically significant 
associations between age and level of immune suppression (p=0.027), 
presence of radiographic abnormalities (p=0.039), parenchymal 
disease (p=0.036), air space disease (p=0.031), and radiographic 
TB (p=0.034). A larger proportion of immune-suppressed children 
were in the 6 - 12 years age group (85% of the group were immune-
suppressed) compared with the other age groups. This may represent 
the criteria for qualification for ART which defined our sample 
population (children >5 years qualify for ART when CD4 <15%, 
i.e. severe immune suppression). The presence of radiographic 
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abnormalities, parenchymal disease and air space disease were also 
more predominant in the 6 - 12 years age group. All 8 (100%) of the 
patients with suspected TB were in the 6 - 12 years age group.
Table II summarises relevant radiographic features according to 
age group.
Of the 31 patients with parenchymal disease on chest radiograph, 24 
(77%) had history of a cough (>2 weeks), 20 (65%) had experienced weight 
loss, 24 (77%) had a history of fever, 27 (87%) had faltered in growth, 14 
(45%) had cervical lymphadenopathy, and 14 (45%) had a diagnosis of 
pulmonary TB (all of whom were on anti-tuberculous treatment).
Of the 8 patients with radiographic features suggestive of TB, 3 had 
a confirmed diagnosis of pulmonary TB and were on TB treatment 
(at the time of the baseline chest radiograph); all 8 had history of a 
TB contact and cough; 4 had a history of weight loss; one had cervical 
lymphadenopathy. All patients were in the 6 - 12 years age group.
Discussion 
Prevalence of specific radiographic features: 
expected baseline radiographic appearances
Baseline chest radiographs in paediatric outpatients presenting for 
initiation of ART are predominantly normal (54%), but also demonstrate 
a significant number of pathological radiological features (46%).
Pulmonary disease is the most common clinical presentation of 
HIV in infants and children.8 This correlated well with our results, 
which demonstrated pulmonary parenchymal disease to be the most 
common (34%) pathological radiological finding. Air-space disease 
was seen in nearly a third of patients.
Respiratory infections are the most common cause of pulmonary 
change on the chest radiographs of HIV-infected children.10 
These include bacterial or viral pneumonias, Pneumocystis jiroveci 
pneumonia (PCP/PJP), or tuberculosis. Bacterial pneumonia typically 
presents as lobar or segmental consolidation with air bronchograms 
(Fig. 1).8,15 Diffuse, bilateral ‘ground-glass’ or alveolar pulmonary 
opacification (air space disease), which may show some asymmetry, 
has been consistently documented as the most common radiographic 
finding in childhood PCP (Fig. 2).16
Air trapping and bronchial disease were also prominent features, 
demonstrated in 10% and 7% of patients respectively (Figs 3 and 
4). Bronchiectasis in children who are HIV-infected may occur as 
a result of recurrent or unresolved pneumonia, as a complication of 
ORIGINAL ARTICLES
Table I. Radiographic features and level of immune suppression in HIV-infected children eligible for initiating antiretroviral therapy 
(figures in parentheses: black values indicate percentages of the total population group; blue values indicate percentages of the total 
per radiographic finding)
Immune suppression
Radiographic findings None Moderate Severe Not recorded Total (%) of 92 patients
Normal chest radiograph 7 (14%) 21 (42%) 19 (38%) 3 (6%) 50 (54%)
Abnormal chest radiograph 9 (21%) 10 (24%) 20 (48%) 3 (7%) 42 (46%)
Mediastinal disease 3 5 11 4 20 (22%)
Cardiomegaly 3 5 10 4 19 (21%)
Lymphadenopathy 0 0 1 0 1 (1%)
Parenchymal disease 8 6 15 2 31 (34%)
Air space disease 8 5 11 2 26 (28%)
Bronchial disease 1 0 4 1 6 (7%)
Air trapping 4 2 2 1 9 (10%)
TB 2 0 5 1 8 (9%)
Table II. Radiographic features and age in HIV-infected children eligible for initiating antiretroviral therapy (figures in parentheses: 
black values indicate percentages of the total population group; blue values indicate percentages of the total per radiographic finding)
Age
Radiographic findings <12 months 1 - 5 years 6 - 12 years Total (%) of 92 patients
Normal chest radiograph 5 (10%) 28 (56%) 17 (34%) 50 (54%)
Abnormal chest radiograph 4 (9.5%) 13 (31%) 25 (59.5%) 42 (46%)
Mediastinal disease 0 6 14 20 (22%)
Cardiomegaly 0 6 13 19 (21%)
Lymphadenopathy 0 0 1 1 (1%)
Parenchymal disease 4 8 19 31 (34%)
Air space disease 3 6 17 26 (28%)
Bronchial disease 0 1 5 6 (7%)
Air trapping 4 3 2 9 (10%)
TB 0 0 8 8 (9%)
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lymphocytic interstitial pneumonitis (LIP), after aspiration, or as a 
result of pulmonary TB.17
Radiographic features suggestive of TB were present in less than a 
tenth of patients (Fig. 5). There were 8 radiographs reported as having 
features of TB, with only one of these demonstrating lymphadenopathy. 
Although the conventional radiological hallmark of primary tuberculosis 
in childhood is hilar and/or mediastinal lymphadenopathy with or 
without concomitant pulmonary disease,18,19 recent studies have shown 
that, in the setting of HIV infection, classical imaging patterns do not 
always apply and atypical disease patterns occur.20
Cardiomegaly was the second most prevalent abnormality (21% 
of patients) (Fig. 6). Cardiac disease in HIV-infected children is 
most commonly due to dilated cardiomyopathy with biventricular 
chamber enlargement.8 Most (25 - 40%) HIV-related heart disease 
is a primary myopathic abnormality. Cardiac enlargement in HIV-
infected children may also be due to primary pulmonary pathology, 
HIV-related obstructive pulmonary vascular disease in the absence of 
lung disease, pericardial disease, or anaemia.10
Lymphadenopathy and pleural disease (1% respectively), were rare 
findings in our cohort of children presenting for initiation of ART.
Comparison: radiographic features and level 
of immune suppression
In HIV-infected adults, specific HIV-related infections and neoplasms 
have occurred within defined CD4 lymphocyte count ranges, which 
aids in narrowing the radiological differential diagnosis.12 We attempted 
to determine whether certain radiographic features predominate at 
specific levels of immune suppression in paediatric patients.
We found no association between immune suppression and 
collective radiological findings. The only specific radiological feature 
that correlated statistically with the level of immune suppression 
was air space disease. This was a negative association, and was 
independent of age. The presence of air space disease correlated with 
a higher level of immunity. This implies that patients with immune 
suppression are less likely to demonstrate parenchymal air space 
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Fig. 1. Chest radiograph demonstrating multi-focal air space disease, 
predominantly in the right upper and middle lobes. The right upper lobe also 
shows central cavitation.
Fig. 2. Chest radiograph demonstrating bilateral symmetrical nodularity 
with early confluence centrally and air trapping as well as a thin-walled, 
air-filled cyst in the right upper zone. Features are consistent with Pneumo-
cystis jiroveci pneumonia (PCP/PJP).
Fig. 3. Chest radiograph demonstrating air trapping with flattening of the 
diaphragms in keeping with acute or chronic small airways disease.
Fig. 4. Chest radiograph demonstrating ring and tubular shadows in the left 
lower lobe consistent with bronchiectasis.
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disease than those who are immune-competent. We postulate that 
this may be due to the decreased ability of the patient’s immune 
system to mount an immune response.
The high incidence of TB in HIV-infected children is due to 
their vulnerability to progress to disease and their increased risk of 
exposure. The risk of TB increases with severe immune suppression: 
a 4 times higher risk in children with CD4 % <15% than in those with 
CD4 % >15%.21 This trend was shown in our study population: of the 
patients with radiographic features of TB, two-thirds were severely 
immune-suppressed, and all had clinically severe disease (WHO 
stages III and IV).
There was no statistically significant association between 
cardiomegaly and immunity, implying that HIV cardiomyopathy is 
not unique to a specific level of immune suppression.
Older children (>6 years) showed a higher tendency to be 
immune-suppressed compared with their younger counterparts. As 
mentioned previously, this may be due to the criteria that qualify 
older children for ART (CD4 <15%, i.e. severe immune suppression). 
When radiographic findings were analysed according to participant 
age categories, older children consistently showed a higher incidence 
of collective radiographic findings, parenchymal disease, air space 
disease, and presence of radiographic TB.
Role of the chest X-ray in ART management
Decision-making about initiating ART is particularly important for 
children <12 months old as the mortality rate in untreated HIV-infected 
infants is high – up to a third die in the first year.13,22 Studies demonstrate 
that early initiation of ART in infancy and in children with advanced disease 
dramatically reduces the risk of mortality and disease progression.22,23 The 
WHO has consequently updated the recommendations regarding the 
optimal time for initiation of ART, advocating treatment of HIV-positive 
infants regardless of CD4 count/percentage.
According to the current national guidelines, eligibility for the 
initiation of ART in confirmed HIV-positive children >1 year old is 
dependent on clinical and immunological criteria, i.e. clinical staging 
(according to the WHO classification), and immune status (according 
to the gold standard – CD4 lymphocyte count/percentage).24
South Africa’s paediatric ART programme is the largest in the 
world.25 Nevertheless, in 2009, less than 70% of the estimated number 
of South African children in need of ART were actually receiving 
it.7 In resource-constrained settings, the WHO recommends the 
use of clinical parameters with or without total lymphocyte count 
to facilitate universal access to ART and enable children to receive 
treatment even when CD4 results are not available.13
However, studies disagree regarding the association between the 
WHO classification of HIV-associated clinical disease and CD4 cell 
count.26-29 Furthermore, absolute lymphocyte count (which is a less 
technical laboratory investigation to perform) does not always correlate 
with severe immune suppression, which is based on CD4 cell count.30 
The chest radiograph therefore plays an inevitable role in decision-
making while developing countries try to cope with the demands 
for wider CD4 count testing and more reliable ways to confirm or 
exclude the diagnosis of tuberculosis. Our study suggests caution when 
interpreting baseline chest X-rays before initiating ART. The majority 
of baseline chest X-rays are normal. There is no correlation between 
radiological findings and level of immune suppression, and there is 
a paradoxical, inverse relationship between immune suppression and 
radiographic air space disease. Therefore, the chest X-ray is not an 
accurate tool in determining a patient’s level of immunity.
Baseline chest radiographs are, however, essential as a comparative 
tool, allowing monitoring of improvement or progression of disease 
as an indication of treatment response. The initial chest X-ray is also 
used to exclude pulmonary TB (in conjunction with clinical findings 
and laboratory tests). This is important as the co-management of TB 
and HIV is complicated by drug interactions between ART and anti-
tuberculosis drugs, as well as the development of IRIS. Therefore, 
although chest radiographs should not be used as a surrogate for 
immunological testing to determine eligibility for ART, knowledge 
of radiographic patterns of disease in children eligible to start ART 
is useful for making other management decisions, especially in 
environments where laboratory testing is limited.
Study limitations
The limitations of this study include the retrospective study design, 
the small sample size, and the selected inclusion/exclusion criteria 
(lack of randomisation). Of importance is the inability to measure 
inter- and intra-observer variation in radiological interpretation 
owing to the use of a single observer and a single observation. Bias 
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Fig. 5. Chest radiograph demonstrating fibrosis with volume loss and bron-
chiectasis involving the left upper lobe, with mediastinal shift to the left, 
probably representing post-primary type TB change in an older child.
Fig. 6. Well-inspired chest radiograph demonstrating cardiomegaly without 
any features of cardiac failure or super-infection.
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is inherent in a retrospective medical record review owing to the 
varying quality of recorded information that may limit the accuracy 
of the accumulated data and lead to under- or over-estimates. The 
population sample size was limited by time constraints. Owing to 
feasibility, only chronically ill outpatients were included. Respiratory 
pathologies affecting acutely ill (hospitalised) patients were therefore 
not represented. These factors, and the limited sample size, hindered 
stratification and generalisability. Correlation between the chest 
radiographic findings and final diagnosis was not performed, but is a 
future research prospect.
Despite the limitations, this study correlated well with previous 
studies21,31 in demonstrating that, as the CD4 percentage decreases in 
HIV-infected children, there is both an increased risk of developing 
TB as well as a decreased ability to mount an immunological response 
and produce a radiographic abnormality (in our case, air space 
disease). In addition, the study has illustrated that a wide range 
of baseline chest radiographic appearances exists at initiation of 
ART, thereby providing a platform for further research, particularly 
regarding IRIS.
Conclusion
Baseline chest radiographs in paediatric outpatients presenting for 
initiation of ART are predominantly normal, but also demonstrate 
a significant number of pathological radiological features, primarily 
air space disease and cardiomegaly. The only statistically significant 
association between radiographic features and immune suppression 
was air space disease, which correlated with a higher level of immunity, 
and was independent of age. Although the chest X-ray is not an 
accurate tool in determining a patient’s level of immunity, baseline 
chest radiographs are vital in excluding pulmonary tuberculosis 
before initiation of ART, and for monitoring treatment response.
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